MedPath

Teveten

Brand Name: Teveten

Generic Name: Eprosartan (As Mesylate)

Active
Registration Number

DRP-301

Dosage Form

Film-Coated Tablet

Issuance Date

February 15, 2022

Expiry Date

February 14, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength600mg
PackagingPhp 516.67 per box

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Angiotensin II antagonist
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Eprosartan (As Mesylate)Active
Monograph: eprosartan (as mesylate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.